Ingevity (NGVT) Q2 2026 Earnings Call Transcript
Ingevity (NGVT) held its Q2 2026 earnings call. Net sales were $314 million, down 5% on reported basis due to the Road Markings divestiture. Adjusted EBITDA rose 14% to $115 million, with margin at 36.6%. Adjusted EPS was $1.74. Free cash flow was $89 million. Full-year guidance for EBITDA and EPS was raised.
How this was made
The 30-second read
Why it matters
Traders should focus on the raised FY2026 EBITDA/EPS/FCF ranges, segment margin drivers (pricing, mix, plant utilization), and the stated demand risks from weaker North America auto production and higher asphalt prices affecting international volumes.
Market read
This is a guidance-and-segment-margins update with a new PFAS municipal contract and explicit second-half demand risks, making it actionable for positioning around FY2026 expectations.
What to watch
Net leverage is at the upper end of the target range (2.5x), which can constrain flexibility if margins compress or if the Advanced Polymer Technologies divestiture process changes timing.
Background
The call covers Q2 2026 performance after divesting the Road Markings product line and discusses ongoing progress on the Advanced Polymer Technologies sale process.
Ticker impact
Ingevity reported Q2 results and raised full-year 2026 adjusted EBITDA guidance to $380m-$400m and EPS to $5.00-$5.45.
Bias modestly positive for the next few sessions, with volatility around second-half utilization normalization and guidance sensitivity to auto production.
The article contains multiple fresh, decision-relevant datapoints: Q2 adjusted EBITDA margin expansion, raised full-year EBITDA/EPS/FCF guidance, and a first municipal PFAS filtration contract. Offsetting risks include weaker back-half North America auto production and higher asphalt prices driving delays and international volume declines.
Market effects
Highlights demand tailwinds from hybrid vehicles for carbon solutions and potential resilience in PFAS filtration-related activated carbon applications.
North America auto production weakness in the back half is flagged as a near-term demand cadence risk.
International markets face project delays and volume pressure tied to higher asphalt pricing and China-related declines.
Counterpoint
Guidance raises may be partially offset by second-half utilization normalization and macro-driven project delays, so upside could fade if volumes do not recover as expected.
Key entities
- companyIngevity Corporation
Reported Q2 2026 results, raised FY2026 guidance, and discussed segment margin expansion and a first municipal PFAS filtration contract.
- executiveDavid H. Li
CEO and President, cited hybrid-vehicle demand and back-half North America auto production weakness.
- executivePhillip J. Platt
CFO, discussed stranded cost elimination and financial drivers behind guidance.